|
⚲
|
| Keyboard |
| Tullis Growth Fund II LP
✚
|
|
|---|---|
| CIK # | 0001746842 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001746842] | |
| 4 | [0001746842] | |
| D | [0001746842] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Tullis James L L | |
| Tullis Growth Fund II LP | |
| Exagen Inc | |
| Tullis Dickerson Partners III LLC | |
| Tullis Dickerson Capital Focus III LP | |
| Tullis Growth Fund LP |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Exagen Inc XGN
Common Stock
|
2023-06-15 | Buy | 167 | $3.11 | 519 |
|
Exagen Inc XGN
Common Stock
|
2020-03-20 | Other | 164,420 | $0.00 | |
|
Exagen Inc XGN
Series H Redeemable Convertible Preferred Stock · derivative
|
2019-09-23 | Conversion | 58,359,932 | ||
|
Exagen Inc XGN
Common Stock
|
2019-09-23 | Conversion | 1,786,853 | $0.00 | |
|
Exagen Inc XGN
Series C Redeemable Convertible Preferred Stock · derivative
|
2019-09-23 | Conversion | 5,446,902 | ||
|
Exagen Inc XGN
Series A-3 Redeemable Convertible Preferred Stock · derivative
|
2019-09-23 | Conversion | 468,321 | ||
|
Exagen Inc XGN
Series F Redeemable Convertible Preferred Stock · derivative
|
2019-09-23 | Conversion | 81,166,266 | ||
|
Exagen Inc XGN
Series E Redeemable Convertible Preferred Stock · derivative
|
2019-09-23 | Conversion | 53,251,030 | ||
|
Exagen Inc XGN
Warrants · derivative
|
2019-09-19 | Option exercise | 11,498 | $14.32 | 164,651 |
|
Exagen Inc XGN
Common Stock
|
2019-09-19 | Option exercise | 11,498 | $14.32 | 164,651 |
|
Exagen Inc XGN
Common Stock
|
2019-09-19 | Tax withheld | 8,865 | $18.58 | 164,712 |